Qualigen Therapeutics Inc...

NASDAQ: QLGN · Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT

Qualigen Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 7.94M 1.63M 1.61M 1.39M 1.44M 1.43M 722.03K 1.48M 1.16M 1.12M 1.9M
Cost of Revenue
n/a n/a n/a 754.29K 364.38K 4.5K 5.59M 1.02M 1.26M 1.1M 1.28M 1.1M 828.85K 1.22M 993.12K 916.62K 1.2M
Gross Profit
n/a n/a n/a -754.29K -364.38K -4.5K 2.35M 610.49K 342.34K 293.73K 163.04K 330.86K -106.82K 260.97K 161.94K 201.31K 697.02K
Operating Income
-2.72M -1.33M -1.27M -1.74M -1.41M -2.27M -2.78M -3.55M -3.69M -58.35K -4.38M -4.14M -5.01M -4.65M -4.81M -7.39M -5.81M
Interest Income
112.95K 80.71K 48.08K n/a n/a n/a n/a n/a n/a n/a 4.63K 4.82K 6.31K n/a 6.8K 12.72K n/a
Pretax Income
-2.65M -850.29K -1.8M -1.48M -2.03M -2.47M -3.24M -3.55M -4.27M -8.8M -4.06M -4.12M -4.32M -6.06M -2.86M -5.3M -3.67M
Net Income
-2.65M -855.82K -1.79M -1.58M -2.03M -2.47M -3.66M -3.46M -4.11M -8.53M -3.83M -4.13M -4.32M -6.06M -2.86M -5.31M -3.67M
Selling & General & Admin
2.49M 1.02M 1.15M 986.48K 1.05M 958.28K 1.34M 2.84M 1.91M 2.93M 2.86M 2.97M 3.04M 3.28M 2.89M 3.09M 3.01M
Research & Development
33.17K -44.94K 123.43K 754.29K 364.38K 1.31M 1.44M 1.33M 2.12M 1.78M 1.69M 1.51M 1.86M 1.63M 2.08M 4.51M 3.5M
Other Expenses
197K 360K n/a n/a -356.66K 5.46K 33.45K 5.68K 4.88K 330.00 1.14K -376 36.00 1.85K 702.00 2.35K 542.00
Operating Expenses
2.72M 1.33M 1.27M 1.74M 1.41M 2.27M 2.78M 4.16M 4.04M 4.7M 4.55M 4.47M 4.9M 4.91M 4.97M 7.6M 6.51M
Interest Expense
73.61K 100.47K 408.36K 263.56K 136.56K 235.81K 367.26K 377.42K 544.24K 6.59M n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -9.74K -4.5K n/a 169.22K 199.11K 267.13K 239.87K 305.1K 138.32K 140.25K 130.22K 135.54K 136.59K
Cost & Expenses
2.72M 1.33M 1.27M 1.74M 1.41M 2.27M 2.78M 5.18M 5.3M 5.8M 5.82M 5.57M 5.73M 6.13M 5.96M 8.51M 7.71M
Income Tax Expense
35.00 5.53K -2.2K -1.21K 1.79K -4.79K n/a -38.18K -163.78K -271.25K -230.77K 5.44K 736.00 3.28K 1.01K 605.00 530.00
Shares Outstanding (Basic)
1.46K 73.64 382K 7.6M 5.94M 5.22M 5.05M 5.05M 4.93M 4.21M 3.94M 3.67M 3.53M 3.13M 2.9M 2.89M 2.76M
Shares Outstanding (Diluted)
1.46K 73.64 387.88K 7.6M 5.94M 5.23M 5.05M 5.05M 4.96M 4.21M 3.94M 3.67M 3.53M 3.13M 2.9M 2.89M 2.82M
EPS (Basic)
-1.82 -11.62K -4.77 -0.21 -0.34 -0.47 -0.72 -0.69 -0.83 -2.03 -0.97 -1.13 -1.22 -1.94 -0.98 -1.84 -1.33
EPS (Diluted)
-1.82 -11.62K -4.7 -0.21 -0.34 -0.47 -0.72 -0.69 -0.83 -2.02 -0.97 -1.13 -1.22 -1.94 -0.98 -1.84 -1.3
EBITDA
-2.72M -749.82K -1.39M -1.21M -1.89M -2.23M -2.78M -3.05M -3.61M -4.92M -3.97M -4.05M -4.92M -4.62M -4.81M -7.39M -5.81M
EBIT
-2.57M -749.82K -1.39M -1.21M -1.89M -2.24M -2.78M -3.17M -3.73M -4.41M -3.47M -4.14M -5.01M -4.65M -4.81M -7.39M -5.81M
Depreciation & Amortization
n/a n/a n/a 1.12K 1.12K 4.5K -239.09K 122.79K 116.3K 83.08K 89.55K 91.82K 84.24K 87.4K 81.94K 77.54K 74.18K